Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.020
-0.060 (-5.56%)
At close: Mar 20, 2026, 4:00 PM EDT
1.020
0.00 (0.00%)
After-hours: Mar 20, 2026, 4:16 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $24.34 million as of March 20, 2026. Its market cap has decreased by -2.06% in one year.
Market Cap
24.34M
Enterprise Value
8.26M
1-Year Change
-2.06%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $24.34M, a decrease of -76.06%. That is a compound annual growth rate of -18.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 256.37M | 53.58% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 28.23M |
| Boundless Bio | 26.22M |
| Barinthus Biotherapeutics | 26.10M |
| NeuroSense Therapeutics | 25.87M |
| Cue Biopharma | 25.82M |
| Lantern Pharma | 25.61M |
| IGC Pharma | 25.59M |
| Senti Biosciences | 25.51M |